HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$2.78
Year range
$1.18 - $4.08
Market cap
476.97M USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.07M | 32.53% |
Net income | -19.88M | -52.04% |
Net profit margin | — | — |
Earnings per share | -0.14 | -40.00% |
EBITDA | -20.97M | -40.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.95M | -30.96% |
Total assets | 116.70M | -25.01% |
Total liabilities | 23.49M | 147.09% |
Total equity | 93.21M | — |
Shares outstanding | 138.28M | — |
Price to book | 4.15 | — |
Return on assets | -42.45% | — |
Return on capital | -47.93% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.88M | -52.04% |
Cash from operations | -11.83M | -10.02% |
Cash from investing | -6.36M | -198.10% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -18.19M | -326.04% |
Free cash flow | -4.95M | 17.93% |
About
Founded
2014
Headquarters
Website
Employees
35
